Ye Hyun Park (Yehyun Park)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Gas Chromatography

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Ultrasound Guided

Top Venues

International journal of molecular sciences

Yonsei medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ye Hyun Park, Jae Bum Ahn, Da Hye Kim, I Seul Park, Mijeong Son, Ji Hyung Kim, Hyun Woo Ma, Seung Won Kim, Jae Hee Cheon
Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease. International journal of molecular sciences 25 (12) (2024)
Ye Hyun Park, Jae Bum Ahn, Da Hye Kim, I Seul Park, Mijeong Son, Ji Hyung Kim, Hyun Woo Ma, Seung Won Kim, Jae Hee Cheon
Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease. International journal of molecular sciences 25 (12) (2024)
Kyung Rok Kim, Ki Nam Shim, A Reum Choe, Min Jong Lee, Ye Hyun Park, Eun Mi Song, Chung Hyun Tae, Sung Ae Jung
A Case of Intramural Gastric Wall Abscess, a Rare Disease Successfully Treated with Endoscopic Incision and Drainage. Gut and liver (2023)
Hong Jun Park, Byung-Wook Kim, Jun Kyu Lee, Ye Hyun Park, Jin Myung Park, Jun Yong Bae, Seung Young Seo, Jae Min Lee, Jee Hyun Lee, Hyung Ku Chon, Jun Won Chung, Hyun Ho Choi, Myung Ha Kim, Dong-Ah Park, Jae Hung Jung, Joo Young Cho, null null
2021 Korean Society of Gastrointestinal Endoscopy Clinical Practice Guidelines for Endoscopic Sedation. Gut and liver 16 (3) (2022)
Yong Il Lee, Ye Hyun Park, Soo Jung Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis. Gut and liver 15 (2) (2021)
Ji Young Chang, Jae Hyun Kim, Joyeon Kang, Ye Hyun Park, Soo Jung Park, Jae Hee Cheon, Byung Chang Kim, Hoguen Kim, Jae Jun Park, Tae Il Kim
mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer. Yonsei medical journal 61 (7) (2020)